Cargando…

Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

BACKGROUND: Natural killer (NK) cells recognize and lyse target tumor cells in an MHC-unrestricted fashion and complement antigen- and MHC-restricted killing by T-lymphocytes. NK cells and T-lymphocytes mediate early killing of targets through a common granzyme B-dependent mechanism. Tumor cell resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedman, Jay, Morisada, Megan, Sun, Lillian, Moore, Ellen C., Padget, Michelle, Hodge, James W., Schlom, Jeffrey, Gameiro, Sofia R., Allen, Clint T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011473/ https://www.ncbi.nlm.nih.gov/pubmed/29925431 http://dx.doi.org/10.1186/s40425-018-0374-2

Ejemplares similares

Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
por: Lee, Maxwell Y, et al.
Publicado: (2021)

A Wee1 checkpoint inhibits anaphase onset
por: Lianga, Noel, et al.
Publicado: (2013)

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
por: Robbins, Yvette, et al.
Publicado: (2020)

Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
por: Toni, Tiffany, et al.
Publicado: (2023)

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
por: Clavijo, Paul E., et al.
Publicado: (2017)

WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
por: Zheng, Hongping, et al.
Publicado: (2017)

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2018)

Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve
por: Fabian, Kellsye P, et al.
Publicado: (2021)

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2019)

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12
por: Franks, S. Elizabeth, et al.
Publicado: (2023)

Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
por: Wolfson, Benjamin, et al.
Publicado: (2021)

PEG Induces High Expression of the Cell Cycle Checkpoint Gene WEE1 in Embryogenic Callus of Medicago truncatula: Potential Link between Cell Cycle Checkpoint Regulation and Osmotic Stress
por: Elmaghrabi, Adel M., et al.
Publicado: (2017)

PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
por: Fabian, Kellsye P, et al.
Publicado: (2020)

DNA replication checkpoint control of Wee1 stability by vertebrate Hsl7
por: Yamada, Ayumi, et al.
Publicado: (2004)

Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition
por: van Harten, Anne M., et al.
Publicado: (2020)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
por: Cetin, Meryem H., et al.
Publicado: (2023)

Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
por: Hoke, Austin T.K., et al.
Publicado: (2021)

Structural conservation of WEE1 and its role in cell cycle regulation in plants
por: Détain, A., et al.
Publicado: (2021)

Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
por: Hicks, Kristin C., et al.
Publicado: (2018)

Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma
por: Anichini, Giulia, et al.
Publicado: (2023)

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
por: Magnussen, Gry Irene, et al.
Publicado: (2013)

Air raids and the 'Wee' Hospital.
por: Logan, C. J. H.
Publicado: (2003)

Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis
por: Du, Ran, et al.
Publicado: (2021)

Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition
por: Wang, Xiaoguang, et al.
Publicado: (2018)

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
por: Harris, Peter S, et al.
Publicado: (2014)

Overcoming hypoxia-induced functional suppression of NK cells
por: Solocinski, Kristen, et al.
Publicado: (2020)

Plant WEE1 kinase is cell cycle regulated and removed at mitosis via the 26S proteasome machinery
por: Cook, Gemma S., et al.
Publicado: (2013)

A Wee Lesson in Science Communication
por: King, Emma
Publicado: (2004)

Pedicures, wees alert op ‘coronatenen’
por: van Putten, Margreet
Publicado: (2020)

WEE1 Inhibitor: Clinical Development
por: Kong, Anthony, et al.
Publicado: (2021)

Not so WEE: Targeting G(2)/M to kill mesothelioma cells
por: Dent, Paul
Publicado: (2014)

Differential Effects of Combined ATR/WEE1 Inhibition in Cancer Cells
por: Rødland, Gro Elise, et al.
Publicado: (2021)

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
por: Lopez, Diana C., et al.
Publicado: (2022)

Regulation of cell size and Wee1 kinase by elevated levels of the cell cycle regulatory protein kinase Cdr2
por: Berg, Rachel A., et al.
Publicado: (2022)

Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
por: Kim, Nayoung, et al.
Publicado: (2018)

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
por: Mariotti, F.R., et al.
Publicado: (2020)

Sphingomyelin is a prospective metabolic immune checkpoint for natural killer cells
por: Ma, Hongdi, et al.
Publicado: (2023)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

C/EBPβ Is a Transcriptional Regulator of Wee1 at the G(2)/M Phase of the Cell Cycle
por: Lee, Ji Hae, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vtb8dtf3eng8os3epdb59tsufb